CLEVELAND BIOLABS INC's ticker is CBLI and the CUSIP is 185860202. A total of 22 filers reported holding CLEVELAND BIOLABS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $33,000 | -25.0% | 16,651 | -2.1% | 0.00% | -33.3% |
| Q2 2020 | $44,000 | +51.7% | 17,013 | 0.0% | 0.00% | +50.0% |
| Q1 2020 | $29,000 | +190.0% | 17,013 | +7.2% | 0.00% | +100.0% |
| Q4 2019 | $10,000 | -37.5% | 15,863 | +1.8% | 0.00% | -50.0% |
| Q3 2019 | $16,000 | – | 15,588 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 320,053 | $1,104,000 | 0.04% |
| Renaissance Technologies | 165,651 | $571,000 | 0.00% |
| VANGUARD GROUP INC | 52,592 | $181,000 | 0.00% |
| UBS Group AG | 4,812 | $17,000 | 0.00% |
| IFP Advisors, Inc | 150 | $1,000 | 0.00% |
| OSAIC HOLDINGS, INC. | 290 | $1,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 100 | $0 | 0.00% |
| PNC FINANCIAL SERVICES GROUP, INC. | 15,000 | $52,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 34 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |